DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Goto S, Goto S.
Selection of a suitable patient population for new antiplatelet therapy from the large clinical trial database of the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-thrombolysis in myocardial infarction 50 (TRA-2P-TIMI50) trial.
Circulation 2015;
131 (12) 1041-1043
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.